Filtered By:
Therapy: Chemotherapy
This page shows you your search results in order of date. This is page number 20.
Order by Relevance | Date
Total 1091 results found since Jan 2013.
When will the stigma of mental health end in medicine?
Imagine being a cancer patient afraid of seeing an oncologist because they would likely need to discuss chemotherapy and all the lifestyle changes that it entails. Imagine being a patient with heart failure afraid of seeing the cardiologist because they may be prescribed a diuretic to remove excess fluid from their body and may need […]Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. Learn more.
Source: Kevin, M.D. - Medical Weblog - November 15, 2018 Category: General Medicine Authors: < a href="https://www.kevinmd.com/blog/post-author/anonymous" rel="tag" > Anonymous < /a > Tags: Physician Psychiatry Source Type: blogs
Senolytic Therapeutics Uses Nanotube-Carried Toxins to Destroy Senescent Cells
Today, I'll point out an analysis from the SENS Research Foundation that covers the approach to selective destruction of senescent cells taken by one of the newly formed biotech startups in the space, Senolytic Therapeutics. This field is hot because it is now well proven that senescent cells are the enemy. They are one of the root causes of aging, accumulating with age to degrade tissue function via the secretion of inflammatory signal molecules. Senescent cells actively maintain an aged, inflamed state of metabolism, resulting in the development of age-related disease and increased mortality.
Senescent cells do se...
Source: Fight Aging! - November 14, 2018 Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs
A Popular Science View of Checkpoint Inhibitor Cancer Immunotherapies
Checkpoint inhibitor therapies are a demonstrably successful approach to cancer immunotherapy. They suppress a mechanism that normally restrains immune cells from attacking other cells. This mechanism is abused by cancers, alongside a variety of other ways in which the immune system can be subverted or quieted. Any advanced tumor tends to have evolved into a state in which it is ignored or even helped by the immune system. Checkpoint inhibitor therapies are an improvement on chemotherapy when it comes to the trade-off between harming the cancer and harming the patient, as well as in the odds of success, but still present r...
Source: Fight Aging! - November 13, 2018 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
Philips and Augusta University Partner to Improve Patient Care: Interview with Philips CMO
A few months ago, we heard about how Philips and Augusta University Health are working together in a long-term partnership for the co-development of clinical solutions such as a hybrid operating room. To learn more about the partnership as well as th...
Source: Medgadget - November 7, 2018 Category: Medical Devices Authors: Michael Batista Tags: Exclusive Medicine Public Health Surgery Source Type: blogs
A patient ’s experience of chemotherapy and radiation
I had my first mammogram at age 35, and for the next 35 years I had mammograms regularly. On my way, I’d pass the entrance to the Thomas Johns Cancer Hospital, outside of Richmond, VA, never thinking that I’d one day cross that threshold myself. When I heard the“C” word, I didn’t know what […]Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. Learn more.
Source: Kevin, M.D. - Medical Weblog - November 7, 2018 Category: General Medicine Authors: < a href="https://www.kevinmd.com/blog/post-author/lynn-lazos" rel="tag" > Lynn Lazos < /a > Tags: Patient Oncology/Hematology Source Type: blogs
Where Does Blood Testing Stand Today?
The dream about a drop of blood signaling a wide range of diagnostic results was shattered with Elizabeth Holmes and the Theranos scam. The machination of the company has set back the innovation of blood testing and investment into the field for years. However, there’s always hope. The Medical Futurist looked around where blood testing stands today and what’s the future it is heading towards.
Dreaming about a home laboratory
Stephen just came home from walking his dog, Barney, an always smiling labrador. The 40-something got off his smart shoes, sat back on the yellow couch that he and her partner, Sara, were fighting ...
Source: The Medical Futurist - November 3, 2018 Category: Information Technology Authors: nora Tags: Biotechnology Business Future of Medicine Medical Professionals Patients Portable Diagnostics Researchers blood blood draw blood test blood testing digital health health market home Innovation laboratory theranos Source Type: blogs
Is cancer truly the enemy?
Cancer is the enemy. So, our immediate desire is to get rid of it, throw it away, and never hear from it again. Current therapies that require living tissue are proving that false. We know that your living tumor tissue is like your fingerprint, unique to each individual patient. It contains information specific to you, your genetic make-up, your cancer and ultimately the thought is, your treatment. If kept alive, instead of being thrown away as medical waste in the operating room, it can unlock treatment options that might not otherwise be considered and save patients from side-effects of ineffective treatmen...
Source: Kevin, M.D. - Medical Weblog - October 26, 2018 Category: General Medicine Authors: < a href="https://www.kevinmd.com/blog/post-author/ken-dixon" rel="tag" > Ken Dixon, MD < /a > Tags: Conditions Oncology/Hematology Source Type: blogs
There ’s no textbook for when your father is dying
On my first day of medical school, my father, a dentist, told me he’d just been diagnosed with stage four pancreatic cancer. Cancer had crept back into my life — except this time not into my body.
At age 12, I was diagnosed with brain cancer. After an aggressive surgery, I was tumor-free for 10 years. Then, at 23, I received the news of an inoperable recurrence.
While going through radiation and chemotherapy, I struggled with how to move forward in the face of endless uncertainty — until I realized that, with or without cancer, everyone lives with uncertainty. Since I never knew what the next day would bring, I d...
Source: Kevin, M.D. - Medical Weblog - October 26, 2018 Category: General Medicine Authors: < a href="https://www.kevinmd.com/blog/post-author/jeremy-pivor" rel="tag" > Jeremy Pivor < /a > Tags: Education Oncology/Hematology Palliative Care Source Type: blogs
Microfluidic Chips to Diagnose and Characterize Cancer: Interview with Prof. Fatih Sarioglu, Georgia Tech
Research into microfluidic devices to aid in cancer diagnosis promises huge leaps in making diagnostics easier and faster. Much of this research is focused on chips that can trap circulating tumor cells (CTCs) which are present in blood samples. CTCs...
Source: Medgadget - October 24, 2018 Category: Medical Devices Authors: Conn Hastings Tags: Diagnostics Exclusive Oncology Source Type: blogs
Meet the Academic Medicine Editorial Board: What Was Your First Publication?
Do all medical educators start out by publishing advanced research? Or do some try their hand at something else first? We asked the members of the Academic Medicine editorial board about their first publication. This is what they said.
M. Brownell Anderson, National Board of Medical Examiners
Except for serving as editor of my high school newspaper, my first publication was: Soler NG, Mast TA, Anderson MB, Kienzler L. A logbook system for monitoring student skills and experiences. J Med Educ. 1981;56:775-777. My first publication as first author was: Anderson MB, Mast TA, Soler NG. A required internal medicine preceptorsh...
Source: Academic Medicine Blog - October 23, 2018 Category: Universities & Medical Training Authors: Journal Staff Tags: Editorial Board Q & A Featured Academic Medicine Anthony R. Artino Jr Brenessa Lindeman Bridget C. O’Brien Carrie L. Byington Christopher S. Candler Colin P. West Denice Cora-Bramble Grace Huang John P. Sánchez M. Brownell Ander Source Type: blogs
Nanoparticles Encapsulating Chemotherapy Drugs to Kill Triple Negative Breast Cancer
The cells of triple negative breast cancer tumors don’t have receptors for estrogen, progesterone, and HER2, the main targets used to attack breast cancers. This is why they’re so difficult to treat, but researchers at George Washington ...
Source: Medgadget - October 3, 2018 Category: Medical Devices Authors: Editors Tags: Nanomedicine Oncology Source Type: blogs
Regulation and Loss of Freedom are to Blame for Much of the Poor Strategy of Past Decades of Cancer Research
FDA bureaucrats see the role of their organization as that of a shield, removing as much risk as possible from medicine. Since it is impossible to remove all risk from any medicine, what this mission means in practice is that no individual bureaucrat ever wants to be held accountable for approving a therapy that later turns out to have unexpected consequences. It doesn't matter if those consequences occur in just a few individuals, while countless others benefit, or even if the medicine in question is actually responsible: the fickle press will rise up in arms; the lawyers will flock. Thus those FDA bureaucrats will always...
Source: Fight Aging! - August 31, 2018 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
Blockchain Token Vouchers for Cannabidiol Products: Interview with CBDoken Founder Alexander Lacina
Medgadget recently spoke with healthcare companies utilizing blockchains to manage storage, access, and sharing of data, as well as services related to data. However, some startups are finding ways to use blockchains for transactions related to phys...
Source: Medgadget - August 27, 2018 Category: Medical Devices Authors: Michael Batista Tags: News Source Type: blogs
Fight Aging! Newsletter, August 27th 2018
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more.
This content is...
Source: Fight Aging! - August 26, 2018 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Clearing Senescent Cells from the Brain Reduces Tau Aggregation and Improves Function in Mouse Models of Alzheimer ' s Disease
Over the past few years researchers have demonstrated, numerous times, that using senolytic therapies to remove a significant fraction of senescent cells from old tissues in mice can reverse aspects of aging, successfully treat multiple age-related diseases that presently have no viable treatment options, and extend healthy life. In an exciting recent addition to this field of research, scientists used the dasatinib and quercetin combination in mouse models of Alzheimer's disease. The result is a restoration of function and a reduction of the characteristic tau aggregation that is a feature of this condition. The researche...
Source: Fight Aging! - August 23, 2018 Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs
